Celerion | Phoenix Celerion CPU logo

Celerion | Phoenix Celerion CPU

Research site
Location
2420 W Baseline Road, Tempe, Arizona, United States of America
Site insights

Top conditions

Type 2 Diabetes Mellitus (6 trials)

Alzheimer Disease (5 trials)

Diabetes Mellitus (5 trials)

Parkinson Disease (3 trials)

Hepatitis B (3 trials)

Top treatments

Itraconazole
Selpercatinib
Rifampin
LY3527723
Donepezil
Omeprazole
MGL-3196
Vedolizumab
Lansoprazole
Midazolam

Parent organization

This site is a part of Celerion

Data sourced from clinicaltrials.gov

Trials

8 of 161
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg

This study investigates the safety, tolerability and dose equivalence of drug IkT-001Pro in healthy volunteers (18 to 55 years old) in comparison to...

Enrolling
CML
Drug: IkT-001Pro
Drug: Imatinib Mesylate

The purposes of this study are to:Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects.Fi...

Enrolling
Healthy Participants
Drug: Placebo for CK-4021586
Drug: CK-4021586

The purposes of this Phase 1 study of EDG-7500 are to:Learn about the safety of EDG-7500 after a single and multiple doses in healthy adultsLearn abo...

Enrolling
Healthy Subjects
Drug: EDG-7500
Drug: Placebo

The main aim of this study is to find out how several doses of TAK-279 affects the body of healthy adults and processes midazolam and repaglinide (ph...

Not yet enrolling
Healthy Volunteers
Drug: TAK-279
Drug: Repaglinide

The purpose of this study is to evaluate the relative bioavailability, food effect, and dose proportionality of a granule formulation of VNZ/TEZ/D-IV...

Enrolling
Cystic Fibrosis
Drug: VNZ/TEZ/D-IVA

A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation...

Not yet enrolling
Healthy Adult Participants
Drug: PORT-77
Drug: Placebo

This study will test the safety and effects of SBT115301 when given as a single dose to healthy adult volunteers. It is the first study being done in...

Active, not recruiting
Safety
Biological: Placebo
Biological: SBT115301

This study in healthy volunteers will provide a basis for evaluation of TRL345 as a first in human study, specifically, important safety, tolerabilit...

Enrolling
Healthy Volunteers
Drug: TRL345, a human monoclonal antibody

Trial sponsors

Takeda logo

Takeda (14 trials)

C

Corium (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems